These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32421492)

  • 1.
    Feng M; Schaff AC; Balish MF
    Microbiology (Reading); 2020 Jul; 166(7):629-640. PubMed ID: 32421492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling persistent
    Feng M; Burgess AC; Cuellar RR; Schwab NR; Balish MF
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33170120
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of Mycoplasma pneumoniae biofilms in vitro and the limited role of motility.
    Feng M; Schaff AC; Cuadra Aruguete SA; Riggs HE; Distelhorst SL; Balish MF
    Int J Med Microbiol; 2018 Apr; 308(3):324-334. PubMed ID: 29426802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.
    Kannan TR; Musatovova O; Balasubramanian S; Cagle M; Jordan JL; Krunkosky TM; Davis A; Hardy RD; Baseman JB
    Mol Microbiol; 2010 Jun; 76(5):1127-41. PubMed ID: 20199607
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ramasamy K; Balasubramanian S; Manickam K; Pandranki L; Taylor AB; Hart PJ; Baseman JB; Kannan TR
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362229
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased Zinc Availability Enhances Initial Aggregation and Biofilm Formation of
    Brown LR; Caulkins RC; Schartel TE; Rosch JW; Honsa ES; Schultz-Cherry S; Meliopoulos VA; Cherry S; Thornton JA
    Front Cell Infect Microbiol; 2017; 7():233. PubMed ID: 28638805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growing and Characterizing Biofilms Formed by Streptococcus pneumoniae.
    Chao Y; Bergenfelz C; Hakansson AP
    Methods Mol Biol; 2019; 1968():147-171. PubMed ID: 30929213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the pathogenicity of Mycoplasma pneumoniae: Focus on community-acquired respiratory distress syndrome toxins.
    Xu N; Fan L; Li L; Guo Y
    Microb Pathog; 2024 Oct; 195():106865. PubMed ID: 39153578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of Aspergillus fumigatus biofilm by Streptococcus pneumoniae: Mycelial fragmentation by hydrogen peroxide.
    Iwahashi J; Kamei K; Watanabe H
    J Infect Chemother; 2020 Aug; 26(8):831-837. PubMed ID: 32414689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfide bond of Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin is essential to maintain the ADP-ribosylating and vacuolating activities.
    Balasubramanian S; Pandranki L; Maupin S; Ramasamy K; Taylor AB; Hart PJ; Baseman JB; Kannan TR
    Cell Microbiol; 2019 Aug; 21(8):e13032. PubMed ID: 30977272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalase Enhances Growth and Biofilm Production of Mycoplasma pneumoniae.
    Simmons WL; Dybvig K
    Curr Microbiol; 2015 Aug; 71(2):190-4. PubMed ID: 25894997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity.
    Bose S; Segovia JA; Somarajan SR; Chang TH; Kannan TR; Baseman JB
    mBio; 2014 Dec; 5(6):. PubMed ID: 25538194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LuxS/AI-2 Quorum-Sensing System of
    Yadav MK; Vidal JE; Go YY; Kim SH; Chae SW; Song JJ
    Front Cell Infect Microbiol; 2018; 8():138. PubMed ID: 29780750
    [No Abstract]   [Full Text] [Related]  

  • 14. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease.
    Chao Y; Marks LR; Pettigrew MM; Hakansson AP
    Front Cell Infect Microbiol; 2014; 4():194. PubMed ID: 25629011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Mycoplasma pneumoniae: An update.
    Chaudhry R; Ghosh A; Chandolia A
    Indian J Med Microbiol; 2016; 34(1):7-16. PubMed ID: 26776112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of magainin 2-derived and rationally designed antimicrobial peptides on Mycoplasma pneumoniae.
    Hayashi K; Misawa T; Goto C; Demizu Y; Hara-Kudo Y; Kikuchi Y
    PLoS One; 2022; 17(1):e0261893. PubMed ID: 35073323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates.
    Hall-Stoodley L; Nistico L; Sambanthamoorthy K; Dice B; Nguyen D; Mershon WJ; Johnson C; Hu FZ; Stoodley P; Ehrlich GD; Post JC
    BMC Microbiol; 2008 Oct; 8():173. PubMed ID: 18842140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.
    Kannan TR; Coalson JJ; Cagle M; Musatovova O; Hardy RD; Baseman JB
    J Infect Dis; 2011 Nov; 204(10):1596-604. PubMed ID: 21957154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms.
    Simmons WL; Daubenspeck JM; Osborne JD; Balish MF; Waites KB; Dybvig K
    Microbiology (Reading); 2013 Apr; 159(Pt 4):737-747. PubMed ID: 23412845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine using community-acquired respiratory distress syndrome toxin as an antigen against Mycoplasma pneumoniae in mice.
    Yoshikawa E; Tamiya S; Inoue Y; Suzuki K; Yoshioka Y
    Biochem Biophys Res Commun; 2022 Feb; 594():81-87. PubMed ID: 35078111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.